These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17086031)

  • 1. Chagas' disease and the use of implantable cardioverter-defibrillators in Brazil.
    Rosa RF; Neto AS; Franken RA
    Am J Geriatr Cardiol; 2006; 15(6):372-6. PubMed ID: 17086031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter defibrillator therapy for patients with chronic Chagas' disease: a randomized trial may not be necessary in high-risk patients.
    Bestetti R; Cardinalli-Neto A
    Europace; 2009 Apr; 11(4):537. PubMed ID: 19279026
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chagas' disease and ischemic stroke].
    Carod-Artal FJ
    Neurologia; 2006 Apr; 21(3):135-49. PubMed ID: 16575627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
    Martinelli M; de Siqueira SF; Sternick EB; Rassi A; Costa R; Ramires JA; Kalil Filho R
    Am J Cardiol; 2012 Oct; 110(7):1040-5. PubMed ID: 22727179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of all-cause 1-year mortality in implantable cardioverter defibrillator patients with chronic Chagas' cardiomyopathy.
    di Toro D; Muratore C; Aguinaga L; Batista L; Malan A; Greco O; Benchetrit C; Duque M; Baranchuk A; Maloney J
    Pacing Clin Electrophysiol; 2011 Sep; 34(9):1063-9. PubMed ID: 21535031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone.
    Gali WL; Sarabanda AV; Baggio JM; Ferreira LG; Gomes GG; Marin-Neto JA; Junqueira LF
    Europace; 2014 May; 16(5):674-80. PubMed ID: 24481778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indeterminate form of Chagas' disease. Proposal of new diagnostic criteria and perspectives for early treatment of cardiomyopathy].
    Marin-Neto JA; Almeida Filho OC; Pazin-Filho A; Maciel BC
    Arq Bras Cardiol; 2002 Dec; 79(6):623-7. PubMed ID: 12532246
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictors of mortality in patients with Chagas' cardiomyopathy and ventricular tachycardia not treated with implantable cardioverter-defibrillators.
    Sarabanda AV; Marin-Neto JA
    Pacing Clin Electrophysiol; 2011 Jan; 34(1):54-62. PubMed ID: 20946310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automatic implantable cardioverter-defibrillators in Chagas' heart disease patients with malignant ventricular arrhythmias.
    Cardinalli-Neto A; Greco OT; Bestetti RB
    Pacing Clin Electrophysiol; 2006 May; 29(5):467-70. PubMed ID: 16689840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probability of occurrence of life-threatening ventricular arrhythmias in Chagas' disease versus non-Chagas' disease.
    Martinelli Filho M; De Siqueira SF; Moreira H; Fagundes A; Pedrosa A; Nishioka SD; Costa R; Scanavacca M; D'Avila A; Sosa E
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1944-6. PubMed ID: 11139963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of microvolt T-wave alternans for predicting outcome in patients with Chagas disease with implantable cardioverter defibrillators.
    Barbosa MPT; da Costa Rocha MO; Neto ES; Brandão FV; Lombardi F; Ribeiro ALP
    Int J Cardiol; 2016 Nov; 222():80-85. PubMed ID: 27467316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.
    Cardinalli-Neto A; Bestetti RB; Cordeiro JA; Rodrigues VC
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1236-40. PubMed ID: 17900257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.
    Cardinalli-Neto A; Bestetti RB; Cordeiro JA
    J Cardiovasc Electrophysiol; 2008 Apr; 19(4):E34-5. PubMed ID: 18298517
    [No Abstract]   [Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillator therapy for primary prevention of sudden cardiac death in patients with severe Chagas cardiomyopathy.
    Cardinalli-Neto A; Nakazone MA; Grassi LV; Tavares BG; Bestetti RB
    Int J Cardiol; 2011 Jul; 150(1):94-5. PubMed ID: 21497920
    [No Abstract]   [Full Text] [Related]  

  • 15. Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America.
    Muratore CA; Batista Sa LA; Chiale PA; Eloy R; Tentori MC; Escudero J; Lima AM; Medina LE; Garillo R; Maloney J
    Europace; 2009 Feb; 11(2):164-8. PubMed ID: 19056745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underutilization of implantable cardioverter-defibrillator in studies proposing risk scores to predict death in Chagas heart disease: Just a reflection of the real world.
    Veloso HH
    Int J Cardiol; 2016 Jan; 203():1082-3. PubMed ID: 26638058
    [No Abstract]   [Full Text] [Related]  

  • 17. Device therapy in Chagas disease heart failure.
    Bestetti RB; Cardinalli-Neto A
    Expert Rev Cardiovasc Ther; 2012 Oct; 10(10):1307-17. PubMed ID: 23190069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke in asymptomatic Trypanosoma cruzi-infected patients.
    Carod-Artal FJ; Vargas AP; Falcao T
    Cerebrovasc Dis; 2011; 31(1):24-8. PubMed ID: 20980750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease.
    Barbosa MP; da Costa Rocha MO; de Oliveira AB; Lombardi F; Ribeiro AL
    Europace; 2013 Jul; 15(7):957-62. PubMed ID: 23376978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chagas cardiomyopathy and implantable cardioverter defibrillator implantation: similarities and differences with dilated cardiomyopathy.
    Milei J; Ambrosio G
    Europace; 2009 Feb; 11(2):140-1. PubMed ID: 19168494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.